Search Tag: HIV-1

IMAGING Management

FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay

2017 18 Feb

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Hologic, Inc. has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV infection... Read more

IMAGING Management

Hologic Launches First Fully Automated, Sample-to-Result Molecular Assay in Europe

2015 16 Dec

-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection --   Hologic, Inc. has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated Panther system.... Read more

IMAGING Management

Hologic Expands its European Virology Portfolio with CE-IVD Certified Assay for HBV Viral Load

2015 10 Dec

-- Aptima® HBV Quant Assay Joins Tests for HIV-1 and HCV on the Fully Automated Panther Instrument -- Hologic, Inc. has earned CE-IVD certification for its Aptima HBV Quant assay on the fully automated Panther® instrument, the Company has announced.   This assay expands the European virology menu available on the Panther system, which previously... Read more

Lab Management

Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA & HIV-1 Assays on DxN VERIS MDS

2015 10 Jun

—Beckman Coulter Diagnostics has obtained CE Marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV- 1)... Read more

Pharmacy Management

Powerful Anti-HIV Agent Can Work in a Vaccine

2015 23 Feb

Scientists from The Scripps Research Institute (TSRI) have announced the creation of a novel drug candidate that is so potent and universally effective that it could possibly work as part of an unconventional vaccine. The remarkable research involved scientists from more than a dozen research institutions and has been published in the journal... Read more